Cargando…
Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations
For over 2000 years, ginseng (roots of Panax ginseng C.A. Meyer) has been used as a traditional herbal medicine. Ginsenosides are bioactive compounds present in ginseng responsible for the pharmacological effects and curing various acute diseases as well as chronic diseases including cardiovascular...
Autores principales: | Murugesan, Mohanapriya, Mathiyalagan, Ramya, Boopathi, Vinothini, Kong, Byoung Man, Choi, Sung-Keun, Lee, Chang-Soon, Yang, Deok Chun, Kang, Se Chan, Thambi, Thavasyappan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565578/ https://www.ncbi.nlm.nih.gov/pubmed/36234555 http://dx.doi.org/10.3390/nano12193427 |
Ejemplares similares
-
In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K
por: Boopathi, Vinothini, et al.
Publicado: (2023) -
Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells)
por: Nahar, Jinnatun, et al.
Publicado: (2022) -
Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria
por: Park, Seong-Eun, et al.
Publicado: (2017) -
Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers—An Overview
por: Mathiyalagan, Ramya, et al.
Publicado: (2022) -
Biotransformation of Ginsenoside Rb(1) to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F(2), and Compound K by Leuconostoc mesenteroides DC102
por: Quan, Lin-Hu, et al.
Publicado: (2011)